Gender disparities in myotonic dystrophy 1

Area of Science:

• Genetics and Molecular Biology
• Neurology
• Endocrinology

Background:

• Myotonic Dystrophy Type 1 (DM1) is an inherited multisystem disorder with variable clinical heterogeneity.
• Predicting DM1 phenotype and prognosis is challenging due to complex factors.
• The influence of gender on DM1 manifestations and progression is not well understood.

Purpose of the Study:

• To analyze gender-related differences in Myotonic Dystrophy Type 1.
• To highlight the implications of these differences for DM1 prognosis, diagnosis, and treatment.
• To advocate for the integration of gender as a key factor in DM1 research and clinical practice.

Main Methods:

• Comprehensive literature review on gender differences in DM1.
• Analysis of existing evidence on DM1 manifestations across genders.
• Synthesis of data regarding clinical heterogeneity and gender-specific complications.

Main Results:

• Emerging evidence suggests distinct patterns: males experience more severe muscular, cardiac, CNS, and respiratory issues.
• Females are more susceptible to ophthalmological, gastrointestinal, and endocrine complications.
• Potential gender-based differences in inheritance patterns warrant further investigation.

Conclusions:

• Gender is a critical, yet often overlooked, factor in Myotonic Dystrophy Type 1.
• Recognizing gender disparities can improve patient outcomes and personalized therapeutic strategies.
• Integrating gender-specific considerations into clinical management and research is essential for advancing DM1 care.